TY  - GEN
AU  - Bodnar,L
AU  - Stec,R
AU  - Cierniak,S
AU  - Synowiec,A
AU  - Wcisło,G
AU  - Jesiotr,M
AU  - Koktysz,R
AU  - Kozłowski,W
AU  - Szczylik,C
TI  - Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines
SN  - 1569-8041
PY  - 2016///0405
KW  - Adult
KW  - Aged
KW  - Carcinoma, Papillary
KW  - drug therapy
KW  - Carcinoma, Renal Cell
KW  - Class I Phosphatidylinositol 3-Kinases
KW  - Everolimus
KW  - therapeutic use
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Humans
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - genetics
KW  - Neoplasm Grading
KW  - Phosphatidylinositol 3-Kinases
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Polymerase Chain Reaction
KW  - Prognosis
KW  - Prospective Studies
KW  - Protein Kinase Inhibitors
KW  - Survival Rate
KW  - TOR Serine-Threonine Kinases
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdv166
ER  -